Skip to content

Enzyme-Immunoassay (Rubella Antibodies)

by Flow Laboratories, Inc. 510(k)

Active United States

510(k) K801098

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK801098 Date16 Sep 1980ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
GOL
Device Class
Class II
Regulation
21 CFR Part 866.3510
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is an enzyme-immunoassay (rubella antibodies), classified under the Antigen, Ha (Including Ha Control), Rubella category (Product Code: GOL). It is designed to detect and quantify rubella antibodies in serum or plasma samples, aiding in the diagnosis of rubella infection or immunity status through immunochemical reactions.

The assay is intended for use in clinical microbiology laboratories and is supplied as a single-use diagnostic kit. It requires no special storage conditions beyond refrigeration (2–8°C) and is not intended for reuse. The device was granted FDA 510(k) clearance (K801098) under the Microbiology advisory committee in 1980, with a Traditional 510(k) review and Substantially Equivalent determination. No MRI safety or sterility claims are specified.

Other devices from Flow Laboratories, Inc.

See all devices from Flow Laboratories, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical purpose does this enzyme-immunoassay kit serve in a lab setting?

    This enzyme-immunoassay kit detects and quantifies rubella antibodies in serum or plasma samples. It helps clinicians determine whether a patient has been previously infected with rubella or has developed immunity, which is critical for diagnosing rubella infection or assessing immunity status in individuals.

  • Is this test kit reusable, or is it meant for single-use only?

    The kit is explicitly designed for single-use only. It is supplied as a diagnostic kit intended to be used once per test, ensuring accuracy and preventing cross-contamination between samples.

  • What storage conditions are required for this enzyme-immunoassay kit?

    The kit does not require special storage conditions beyond standard refrigeration. It should be stored between 2°C and 8°C to maintain its integrity and performance for diagnostic testing.

  • How was this device’s regulatory pathway determined, and what does that mean for its use?

    This device received FDA 510(k) clearance under the Microbiology advisory committee in 1980, with a determination of *substantially equivalent* to a predicate device. This means the device was reviewed as a Traditional 510(k) submission and deemed comparable to existing technology in its category, allowing it to be legally marketed for its intended use in clinical microbiology labs.

  • Where is this device manufactured, and who is the applicant responsible for its regulatory submission?

    The device is manufactured by Flow Laboratories, Inc., which is also the applicant responsible for the FDA submission. The manufacturer’s address listed in the records is 803 N. Front St. Suite 3, McHenry, IL 60050, USA.